| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.971 | 0.004 | 0.987 | Analgesic | 0.987 0.003 CID_10105008 | CID_10105008 | |
| 0.876 | 0.001 | 0.876 | Hematopoietic | 0.754 0.003 CID_10105008 | ||
| 0.721 | 0.004 | 0.721 | Psychostimulant | 0.444 0.016 CID_10105008 | ||
| 0.701 | 0.004 | 0.701 | Glutamate receptor antagonist | 0.589 0.004 CID_10105008 | ||
| 0.694 | 0.005 | 0.694 | Anticonvulsant | 0.41 0.021 CID_10105008 | ||
| 0.689 | 0.004 | 0.689 | Anesthetic general | 0.52 0.007 CID_10105008 | ||
| 0.672 | 0.003 | 0.672 | NMDA 2B receptor antagonist | 0.385 0.004 CID_10105008 | ||
| 0.603 | 0.004 | 0.603 | NMDA receptor antagonist | 0.58 0.004 CID_10105008 | ||
| 0.569 | 0.005 | 0.569 | P-glycoprotein inhibitor | 0.309 0.027 CID_10105008 | ||
| 0.503 | 0.003 | 0.503 | NMDA 2A receptor antagonist | 0.277 0.004 CID_10105008 | ||
| 0.458 | 0.003 | 0.458 | NMDA 2C receptor antagonist | 0.312 0.004 CID_10105008 | ||
| 0.456 | 0.003 | 0.456 | NMDA receptor subunit 3A antagonist | 0.268 0.004 CID_10105008 | ||
| 0.434 | 0.003 | 0.434 | NMDA receptor subunit 3B antagonist | 0.287 0.004 CID_10105008 | ||
| 0.404 | 0.004 | 0.404 | NMDA 2 receptor antagonist | 0.232 0.007 CID_10105008 | ||
| 0.464 | 0.103 | 0.71 | Antiinflammatory | 0.71 0.029 CID_10105008 | CID_10105008 | |
| 0.347 | 0.005 | 0.347 | Analgesic, opioid | 0.177 0.011 CID_10105008 | ||
| 0.37 | 0.075 | 0.473 | GABA C receptor rho-3 antagonist | 0.473 0.034 CID_10105008 | CID_10105008 | |
| 0.301 | 0.044 | 0.347 | 5 Hydroxytryptamine uptake stimulant | 0.347 0.026 CID_10105008 | CID_10105008 | |
| 0.369 | 0.131 | 0.369 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.275 0.249 CID_10105008 | ||
| 0.206 | 0.004 | 0.206 | Nociceptin (N/OFQ) receptor antagonist | 0.034 0.026 CID_10105008 | ||
| 0.288 | 0.104 | 0.315 | Calcium channel activator | 0.315 0.078 CID_10105008 | CID_10105008 | |
| 0.221 | 0.058 | 0.228 | Neurotrophic factor enhancer | 0.228 0.053 CID_10105008 | CID_10105008 | |
| 0.246 | 0.091 | 0.373 | 5 Hydroxytryptamine release stimulant | 0.373 0.051 CID_10105008 | CID_10105008 | |
| 0.22 | 0.073 | 0.25 | RNA-directed DNA polymerase inhibitor | 0.25 0.05 CID_10105008 | CID_10105008 | |
| 0.26 | 0.118 | 0.287 | Cholesterol antagonist | 0.287 0.1 CID_10105008 | CID_10105008 | |
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | |||
| 0.176 | 0.041 | 0.176 | Calcium channel blocker | |||
| 0.18 | 0.054 | 0.198 | Arachidonic acid antagonist | 0.198 0.035 CID_10105008 | CID_10105008 | |
| 0.126 | 0.002 | 0.126 | NMDA receptor phencyclidine site antagonist | 0.057 0.003 CID_10105008 | ||
| 0.224 | 0.099 | 0.282 | Interleukin agonist | 0.282 0.058 CID_10105008 | CID_10105008 | |
| 0.221 | 0.101 | 0.264 | Tyrosine 3 hydroxylase inhibitor | 0.264 0.055 CID_10105008 | CID_10105008 | |
| 0.13 | 0.014 | 0.13 | Calcium channel L-type blocker | 0.067 0.057 CID_10105008 | ||
| 0.157 | 0.041 | 0.157 | Pregnane X receptor agonist | 0.149 0.054 CID_10105008 | ||
| 0.274 | 0.162 | 0.274 | MAP kinase kinase 6 inhibitor | |||
| 0.146 | 0.035 | 0.146 | Calcium channel (voltage-sensitive) blocker | |||
| 0.189 | 0.083 | 0.189 | 5 Hydroxytryptamine 3E antagonist | 0.183 0.097 CID_10105008 | ||
| 0.286 | 0.181 | 0.308 | 5 Hydroxytryptamine release inhibitor | 0.308 0.156 CID_10105008 | CID_10105008 | |
| 0.136 | 0.031 | 0.186 | Creatine kinase inhibitor | 0.186 0.013 CID_10105008 | CID_10105008 | |
| 0.112 | 0.011 | 0.112 | Antidiuretic hormone antagonist | 0.072 0.017 CID_10105008 | ||
| 0.11 | 0.02 | 0.451 | Protein kinase B beta inhibitor | 0.451 0.003 CID_10105008 | CID_10105008 | |
| 0.097 | 0.009 | 0.097 | Potassium channel intermediate-conductance Ca-activated blocker | 0.092 0.011 CID_10105008 | ||
| 0.205 | 0.125 | 0.205 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.09 | 0.015 | 0.09 | Opioid agonist | 0.05 0.04 CID_10105008 | ||
| 0.153 | 0.083 | 0.153 | Sigma receptor agonist | 0.135 0.097 CID_10105008 | ||
| 0.109 | 0.042 | 0.109 | Opioid antagonist | |||
| 0.103 | 0.038 | 0.163 | Glutamate release inhibitor | 0.163 0.007 CID_10105008 | CID_10105008 | |
| 0.087 | 0.024 | 0.087 | NMDA receptor glycine site agonist | 0.077 0.03 CID_10105008 | ||
| 0.074 | 0.01 | 0.074 | Potassium channel (Inward rectifier) activator | 0.064 0.016 CID_10105008 | ||
| 0.185 | 0.121 | 0.185 | Peptidyltransferase inhibitor | |||
| 0.096 | 0.033 | 0.096 | Opioid mu receptor antagonist | |||
| 0.157 | 0.095 | 0.183 | Lipocortins synthesis antagonist | 0.183 0.068 CID_10105008 | CID_10105008 | |
| 0.07 | 0.01 | 0.07 | Potassium channel (ATP-sensitive) activator | 0.061 0.015 CID_10105008 | ||
| 0.077 | 0.018 | 0.077 | Dopamine transporter inhibitor | |||
| 0.142 | 0.085 | 0.16 | GABA C receptor rho-2 antagonist | 0.16 0.061 CID_10105008 | CID_10105008 | |
| 0.176 | 0.119 | 0.226 | Aldehyde oxidase inhibitor | 0.226 0.092 CID_10105008 | CID_10105008 | |
| 0.156 | 0.101 | 0.193 | Succinate dehydrogenase inhibitor | 0.193 0.055 CID_10105008 | CID_10105008 | |
| 0.078 | 0.026 | 0.078 | Dopamine uptake inhibitor | |||
| 0.193 | 0.144 | 0.193 | MAP kinase kinase 3 inhibitor | |||
| 0.136 | 0.091 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.15 0.042 CID_10105008 | CID_10105008 | |
| 0.075 | 0.032 | 0.075 | NMDA receptor agonist | 0.071 0.035 CID_10105008 | ||
| 0.139 | 0.097 | 0.139 | CF transmembrane conductance regulator agonist | |||
| 0.176 | 0.138 | 0.212 | Nitric-oxide synthase stimulant | 0.212 0.07 CID_10105008 | CID_10105008 | |
| 0.084 | 0.051 | 0.084 | T cell inhibitor | |||
| 0.125 | 0.093 | 0.125 | CC chemokine 6 receptor antagonist | |||
| 0.103 | 0.072 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.142 0.04 CID_10105008 | CID_10105008 | |
| 0.115 | 0.083 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.088 CID_10105008 | ||
| 0.09 | 0.06 | 0.09 | Potassium channel activator | |||
| 0.097 | 0.067 | 0.111 | GABA C receptor rho-1 antagonist | 0.111 0.049 CID_10105008 | CID_10105008 | |
| 0.033 | 0.004 | 0.036 | Somatostatin 3 agonist | 0.036 0.004 CID_10105008 | CID_10105008 | |
| 0.082 | 0.053 | 0.089 | Glycine receptor antagonist | 0.089 0.044 CID_10105008 | CID_10105008 | |
| 0.083 | 0.054 | 0.083 | Opioid kappa receptor antagonist | |||
| 0.096 | 0.068 | 0.112 | Anabolic | 0.112 0.047 CID_10105008 | CID_10105008 | |
| 0.041 | 0.013 | 0.041 | Histamine H3 receptor agonist | |||
| 0.108 | 0.08 | 0.108 | Interleukin 8 antagonist | |||
| 0.058 | 0.037 | 0.063 | Pregnane X receptor antagonist | 0.063 0.025 CID_10105008 | CID_10105008 | |
| 0.092 | 0.071 | 0.125 | UDP-glucose 4-epimerase inhibitor | 0.125 0.04 CID_10105008 | CID_10105008 | |
| 0.031 | 0.016 | 0.036 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.036 0.013 CID_10105008 | CID_10105008 | |
| 0.052 | 0.038 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.029 | 0.015 | 0.029 | Hedgehog signaling activator | |||
| 0.017 | 0.004 | 0.018 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.018 0.004 CID_10105008 | CID_10105008 | |
| 0.027 | 0.014 | 0.027 | NMDA receptor glycine site antagonist | |||
| 0.033 | 0.021 | 0.042 | Somatostatin agonist | 0.042 0.016 CID_10105008 | CID_10105008 | |
| 0.072 | 0.06 | 0.072 | Vanilloid 4 agonist | |||
| 0.095 | 0.086 | 0.118 | GABA C receptor antagonist | 0.118 0.054 CID_10105008 | CID_10105008 | |
| 0.123 | 0.117 | 0.132 | Adenylate cyclase stimulant | 0.132 0.097 CID_10105008 | CID_10105008 | |
| 0.063 | 0.057 | 0.372 | Protein kinase B alpha inhibitor | 0.372 0.003 CID_10105008 | CID_10105008 | |
| 0.063 | 0.058 | 0.097 | Glutamate (mGluR6) antagonist | 0.097 0.012 CID_10105008 | CID_10105008 | |
| 0.051 | 0.047 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.045 CID_10105008 | CID_10105008 | |
| 0.068 | 0.065 | 0.097 | GABA aminotransferase inhibitor | 0.097 0.029 CID_10105008 | CID_10105008 | |
| 0.04 | 0.037 | 0.04 | Nerve growth factor antagonist | |||
| 0.09 | 0.089 | 0.132 | Cystathionine beta-synthase inhibitor | 0.132 0.05 CID_10105008 | CID_10105008 | |
| 0.113 | 0.114 | 0.123 | Mannose-6-phosphate isomerase inhibitor | 0.123 0.096 CID_10105008 | CID_10105008 | |
| 0.048 | 0.05 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | 0.067 0.023 CID_10105008 | CID_10105008 | |
| 0.014 | 0.015 | 0.014 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.014 0.012 CID_10105008 | CID_10105008 | |
| 0.077 | 0.079 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.053 CID_10105008 | CID_10105008 | |
| 0.09 | 0.098 | 0.139 | DOPA decarboxylase inhibitor | 0.139 0.028 CID_10105008 | CID_10105008 | |
| 0.122 | 0.13 | 0.144 | Interferon gamma antagonist | 0.144 0.086 CID_10105008 | CID_10105008 | |
| 0.054 | 0.064 | 0.057 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.053 CID_10105008 | CID_10105008 | |
| 0.067 | 0.078 | 0.077 | Carbonic anhydrase VI inhibitor | 0.077 0.061 CID_10105008 | CID_10105008 | |
| 0.035 | 0.048 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 CID_10105008 | CID_10105008 | |
| 0.057 | 0.075 | 0.067 | Calcium channel P-type blocker | 0.067 0.036 CID_10105008 | CID_10105008 | |
| 0.105 | 0.125 | 0.137 | Diuretic | 0.137 0.088 CID_10105008 | CID_10105008 | |
| 0.061 | 0.084 | 0.106 | Acetylcholine nicotinic antagonist | 0.106 0.036 CID_10105008 | CID_10105008 | |
| 0.144 | 0.167 | 0.164 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.164 0.118 CID_10105008 | CID_10105008 | |
| 0.026 | 0.052 | 0.045 | Glutamate (mGluR3) antagonist | 0.045 0.016 CID_10105008 | CID_10105008 | |
| 0.07 | 0.106 | 0.08 | Bromodomain-containing protein 2 inhibitor | 0.08 0.076 CID_10105008 | CID_10105008 | |
| 0.073 | 0.116 | 0.101 | Electrolyte absorption antagonist | 0.101 0.056 CID_10105008 | CID_10105008 | |
| 0.024 | 0.068 | 0.043 | Dopamine D5 agonist | 0.043 0.024 CID_10105008 | CID_10105008 | |
| 0.044 | 0.088 | 0.085 | Neuronal nicotinic receptor antagonist | 0.085 0.032 CID_10105008 | CID_10105008 | |
| 0.069 | 0.118 | 0.139 | GABA C receptor agonist | 0.139 0.039 CID_10105008 | CID_10105008 | |
| 0.066 | 0.116 | 0.092 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.092 0.063 CID_10105008 | CID_10105008 | |
| 0.056 | 0.106 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.047 CID_10105008 | CID_10105008 | |
| 0.06 | 0.111 | 0.079 | GABA B receptor agonist | 0.079 0.044 CID_10105008 | CID_10105008 | |
| 0.123 | 0.176 | 0.147 | Phospholipase C inhibitor | 0.147 0.112 CID_10105008 | CID_10105008 | |
| 0.108 | 0.166 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.11 CID_10105008 | CID_10105008 | |
| 0.06 | 0.12 | 0.121 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 CID_10105008 | CID_10105008 | |
| 0.03 | 0.094 | 0.064 | Argininosuccinate synthase inhibitor | 0.064 0.034 CID_10105008 | CID_10105008 | |
| 0.061 | 0.136 | 0.096 | NADH dehydrogenase inhibitor | 0.096 0.048 CID_10105008 | CID_10105008 | |
| 0.024 | 0.101 | 0.036 | Glutamate (mGluR8) agonist | 0.036 0.03 CID_10105008 | CID_10105008 | |
| 0.08 | 0.159 | 0.103 | Cathepsin H inhibitor | 0.103 0.101 CID_10105008 | CID_10105008 | |
| 0.027 | 0.107 | 0.053 | Alcohol oxidase inhibitor | 0.053 0.042 CID_10105008 | CID_10105008 | |
| 0.066 | 0.153 | 0.092 | Carbonic anhydrase XV inhibitor | 0.092 0.079 CID_10105008 | CID_10105008 | |
| 0.044 | 0.132 | 0.064 | Secretase beta inhibitor | 0.064 0.062 CID_10105008 | CID_10105008 | |
| 0.166 | 0.257 | 0.228 | Interleukin 2 agonist | 0.228 0.145 CID_10105008 | CID_10105008 | |
| 0.131 | 0.223 | 0.201 | Superoxide dismutase inhibitor | 0.201 0.116 CID_10105008 | CID_10105008 | |
| 0.06 | 0.153 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | 0.088 0.075 CID_10105008 | CID_10105008 | |
| 0.027 | 0.129 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.059 0.044 CID_10105008 | CID_10105008 | |
| 0.071 | 0.182 | 0.116 | Acetylcholine release stimulant | 0.116 0.055 CID_10105008 | CID_10105008 | |
| 0.075 | 0.186 | 0.147 | Peroxidase inhibitor | 0.147 0.08 CID_10105008 | CID_10105008 | |
| 0.04 | 0.154 | 0.087 | Protein kinase B gamma inhibitor | 0.087 0.041 CID_10105008 | CID_10105008 | |
| 0.021 | 0.14 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.031 CID_10105008 | CID_10105008 | |
| 0.128 | 0.257 | 0.192 | DNA synthesis inhibitor | 0.192 0.136 CID_10105008 | CID_10105008 | |
| 0.052 | 0.212 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.071 CID_10105008 | CID_10105008 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |